Education
About Us
Working with TipRanks
Follow Us
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -77.00K | $ 0.00 |
| Operating Income | $ -38.11M | $ -54.55M | $ -69.64M | $ -42.26M | $ -21.57M |
| EBITDA | $ -38.11M | $ 3.23M | $ 4.90M | $ -40.88M | $ -21.57M |
| Net Income | $ -35.17M | $ -51.32M | $ -64.73M | $ -40.96M | $ -21.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 58.00M | $ 83.62M | $ 107.30M | $ 96.06M | $ 58.55M |
| Total Assets | $ 61.95M | $ 92.09M | $ 138.74M | $ 102.56M | $ 65.32M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 53.00K | $ 0.00 |
| Net Debt | $ -19.94M | $ -21.35M | $ -15.65M | $ -27.17M | $ -12.10M |
| Total Liabilities | $ 8.89M | $ 10.24M | $ 14.04M | $ 7.19M | $ 3.41M |
| Stockholders' Equity | $ 53.06M | $ 81.85M | $ 124.70M | $ 95.37M | $ 61.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.83M | $ -49.26M | $ -53.29M | $ -33.46M | $ -20.48M |
| Operating Cash Flow | $ -29.83M | $ -49.26M | $ -53.29M | $ -33.46M | $ -20.48M |
| Investing Cash Flow | $ 28.31M | $ 54.59M | $ -43.28M | $ -21.77M | $ -50.02M |
| Financing Cash Flow | $ 113.00K | $ 372.00K | $ 84.99M | $ 70.36M | $ 78.53M |